Scotland considers screening patients on admission to hospital to cut infectionsBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39276.461424.DB (Published 19 July 2007) Cite this as: BMJ 2007;335:116
- Bryan Christie
Scotland is considering screening patients for methicillin resistant Staphylococcus aureus (MRSA) when they are admitted to hospital, to help reduce the incidence of healthcare associated infections.
The move comes after the completion of a comprehensive study of the prevalence of such infections in Scotland, which found that 9.5% of patients contract an infection while in Scottish hospitals. The annual cost is calculated to be £183m (€270m; $370m).
The study, carried out by Health Protection Scotland, was based on a survey of almost 14 000 patients—the entire acute hospital population at the time of the survey …
Log in using your username and password
Log in through your institution
Sign up for a free trial